×
About 1,915 results

ALLMedicine™ Androstenedione Center

Research & Reviews  667 results

GNAS mutation is an unusual cause of primary adrenal insufficiency: a case report.
https://doi.org/10.1186/s12887-022-03517-6
BMC Pediatrics; Tong Y, Yue D et. al.

Aug 5th, 2022 - Primary adrenal insufficiency in children has non-specific and extensive clinical features, so the diagnosis of its etiology is complex and challenging. Although congenital adrenal hyperplasia is the most common cause, more and more other genetic ...

Study of Adrenal Gland Tumors
https://clinicaltrials.gov/ct2/show/NCT00005927

Aug 4th, 2022 - The adrenal glands are the major source in the body of the steroid hormones. In normal physiology, the pituitary hormone ACTH regulates the secretion of glucocorticoids, while the secretion of mineralocorticoids such as aldosterone is controlled b...

Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
https://clinicaltrials.gov/ct2/show/NCT03718234

Aug 2nd, 2022 - This is an open-label, non-randomized crossover design feasibility trial comparing oral hydrocortisone treatment with interval bolus delivery (pulsatile) of subcutaneous hydrocortisone via infusion pump in children with congenital adrenal hyperpla...

COVID-19 patients with altered steroid hormone levels are more likely to have higher di...
https://doi.org/10.1007/s12020-022-03140-6
Endocrine Sezer S, Bal C et. al.

Jul 31st, 2022 - This study aims to evaluate the correlations between the severity of the disease and serum steroid levels by analyzing the serum steroid levels in COVID-19 patients with different levels of disease progression and the control group. Morning serum ...

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
https://clinicaltrials.gov/ct2/show/NCT02500147

Jul 20th, 2022 - PCOS subjects will be screened by questionnaire for eligibility with the goal of recruiting 40 subjects who are 14 to 25 years, BMI between the 10th and 95th percentile for age (<20 years) and 18.5 - 29.9 kg/m2 (20 years or older), and at least tw...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  69 results

Study of Adrenal Gland Tumors
https://clinicaltrials.gov/ct2/show/NCT00005927

Aug 4th, 2022 - The adrenal glands are the major source in the body of the steroid hormones. In normal physiology, the pituitary hormone ACTH regulates the secretion of glucocorticoids, while the secretion of mineralocorticoids such as aldosterone is controlled b...

Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
https://clinicaltrials.gov/ct2/show/NCT03718234

Aug 2nd, 2022 - This is an open-label, non-randomized crossover design feasibility trial comparing oral hydrocortisone treatment with interval bolus delivery (pulsatile) of subcutaneous hydrocortisone via infusion pump in children with congenital adrenal hyperpla...

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
https://clinicaltrials.gov/ct2/show/NCT02500147

Jul 20th, 2022 - PCOS subjects will be screened by questionnaire for eligibility with the goal of recruiting 40 subjects who are 14 to 25 years, BMI between the 10th and 95th percentile for age (<20 years) and 18.5 - 29.9 kg/m2 (20 years or older), and at least tw...

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT02770391

Jun 21st, 2022 - Primary Objective: To evaluate the differential effect of neo-adjuvant leuprolide and Apalutamide on dihydrotestosterone (DHT) concentration in benign prostate tissue based on HSD3B1 genotype. Secondary Objective(s): To evaluate the differential e...

Time-restricted Eating to Improve Metabolic Abnormalities in Polycystic Ovarian Syndrome
https://clinicaltrials.gov/ct2/show/NCT05126199

Jun 3rd, 2022 - Background: Polycystic ovarian syndrome (PCOS) is the most common reproductive endocrinopathy in women of reproductive age with many associated metabolic symptoms, in particular hyperinsulinemia, insulin resistance and a high lifetime risk of type...

see more →

News  28 results

Two Distinct Subtypes of PCOS Identified in Adolescents
https://www.medscape.com/viewarticle/975815

Jun 17th, 2022 - Polycystic ovary syndrome (PCOS) in adolescents appears to present as two distinct subtypes based on the presence or absence of obesity, new data show. The findings support the "metabolic" and "reproductive" subtypes previously identified in adult...

Novel Agents in the Management of Castration-Resistant Metastatic Prostate Cancer
https://www.onclive.com/view/novel-agents-in-the-management-of-castration-resistant-metastatic-prostate-cancer

Dec 5th, 2020 - The Prostate Cancer Clinical States model was first proposed by Scher and colleagues nearly 10 years ago. As this model has been refined, it provides a framework for thinking about prostate cancer from a clinical management perspective and in the ...

What is optimal hormonal treatment for women with polycystic ovary syndrome?
https://www.mdedge.com/obgyn/article/215217/gynecology/what-optimal-hormonal-treatment-women-polycystic-ovary-syndrome
Robert L. Barbieri, MD

Jan 8th, 2020 - Polycystic ovary syndrome (PCOS) is the triad of oligo-ovulation resulting in oligomenorrhea, hyperandrogenism and, often, an excess number of small antral follicles on high-resolution pelvic ultrasound. One meta-analysis reported that, in women o.

Testosterone May Underlie Rare Blindness Condition in Women
https://www.medscape.com/viewarticle/911211

Apr 2nd, 2019 - A disease that causes chronic headaches and even blindness in women, and has puzzled researchers for more than 100 years, may be caused by excess androgens, particularly testosterone, that modulate secretion of cerebrospinal fluid (CSF), UK invest...

Treating polycystic ovary syndrome: Start using dual medical therapy
https://www.mdedge.com/obgyn/article/134656/gynecology/treating-polycystic-ovary-syndrome-start-using-dual-medical-therapy
Robert L. Barbieri, MD

Mar 29th, 2017 - Using the Rotterdam criteria, the diagnosis of polycystic ovary syndrome (PCOS) is made in the presence of 2 of the following 3 criteria1: oligo-ovulation or anovulation hyperandrogenism manifested by the presence of either hirsutism or elevated h.

see more →